Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
Age
1–17
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
T1D for at least 6 months at the screening visit.
Have been treated with only one of the following rapid-acting insulin analogs as part of an multiple daily injection regimen for at least the last 90 days prior to the screening visit:
* insulin lispro U-100, or
* insulin aspart
* insulin glulisine or
* fast acting insulin aspart
Have been treated with only one of the following basal insulins for at least the last 90 days prior to the screening visit:
* insulin glargine U-100 (once a day \[QD\] or twice a day \[BID\]), or
* insulin detemir U-100 (QD or BID), or
* insulin degludec U-100 (QD)
Have a HbA1c value ≤ 9.9% at the screening visit.
You may not be if
Have current hypoglycemic unawareness or have had more than 1 episode of severe hypoglycemia within 6 months prior to the screening visit.
Have had more than 1 emergency room visit or hospitalization due to poor glucose control within 6 months prior to the screening visit.
Have been on a treatment regimen that includes regular human insulin, neutral protamine Hagedorn (NPH), Afrezza® (insulin human) inhalation powder, any premixed insulins or use of diluted insulins within 90 days prior to the screening visit.
